Correlation Between Cyxone AB and ExpreS2ion Biotech

Can any of the company-specific risk be diversified away by investing in both Cyxone AB and ExpreS2ion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyxone AB and ExpreS2ion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyxone AB and ExpreS2ion Biotech Holding, you can compare the effects of market volatilities on Cyxone AB and ExpreS2ion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyxone AB with a short position of ExpreS2ion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyxone AB and ExpreS2ion Biotech.

Diversification Opportunities for Cyxone AB and ExpreS2ion Biotech

0.66

Correlation Coefficient

Cyxone AB  ExpreS2ion Biotech

Poor diversification

The 3 months correlation between Cyxone and ExpreS2ion is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Cyxone AB and ExpreS2ion Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ExpreS2ion Biotech and Cyxone AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyxone AB are associated (or correlated) with ExpreS2ion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ExpreS2ion Biotech has no effect on the direction of Cyxone AB i.e., Cyxone AB and ExpreS2ion Biotech go up and down completely randomly.

Pair Corralation between Cyxone AB and ExpreS2ion Biotech

Assuming the 90 days trading horizon Cyxone AB is expected to generate 2.42 times more return on investment than ExpreS2ion Biotech. However, Cyxone AB is 2.42 times more volatile than ExpreS2ion Biotech Holding. It trades about -0.03 of its potential returns per unit of risk. ExpreS2ion Biotech Holding is currently generating about -0.07 per unit of risk. If you would invest  3.90  in Cyxone AB on October 25, 2024 and sell it today you would lose (2.10) from holding Cyxone AB or give up 53.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	81.03%
Values	Daily Returns

Cyxone AB  vs.  ExpreS2ion Biotech Holding

Cyxone AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyxone AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

ExpreS2ion Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ExpreS2ion Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cyxone AB and ExpreS2ion Biotech

The main advantage of trading using opposite Cyxone AB and ExpreS2ion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyxone AB position performs unexpectedly, ExpreS2ion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will offset losses from the drop in ExpreS2ion Biotech's long position.

The idea behind Cyxone AB and ExpreS2ion Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.